Adherium Ltd
Adherium: Scaling Digital Respiratory Care and Assessing the US Payer Opportunity
Adherium pivots to US RPM subscriptions, pursuing Value-Based Care contracts as iCARE validates cost savings; targets 10k shipments and 40k patients in FY2026.
Adherium Surpasses CY2025 Shipment Milestones, Bolstering RPM Growth Strategy
Adherium beats CY2025 targets, shipping 4,666 devices (2,034 RPM) vs 4,000 total; fueling growth toward 10,000 RPM patients by CY2026.
Market wrap: Australian market follows Wall Street down
Once again, an Australian encore followed a Wall Street sell-off as investors grew increasingly nervous about the prospect for rate falls, with bond yields rising and shares in interest rate sensitive areas falling. Weakness in commodity prices didn’t help the Australian market, with falling prices for iron ore and gold helping to broaden the decline […]
Adherium partners with AstraZeneca for Hailie Smartinhaler clinical trial
Digital health solutions specialist Adherium (ASX: ADR) is celebrating news that global biopharmaceutical giant AstraZeneca has selected its Hailie Smartinhaler platform for a clinical trial. Under the contract, valued at $1.1 million, AstraZeneca will use the devices to record and transfer medication usage data over a period of three years. Adherium will provide Hailie Smartinhalers, […]